We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Zotefoams Plc | LSE:ZTF | London | Ordinary Share | GB0009896605 | ORD 5P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -2.00 | -0.46% | 430.00 | 93,665 | 16:35:21 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 426.00 | 433.00 | 430.00 | 428.00 | 430.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Plastics Foam Products | 126.98M | 9.24M | 0.1892 | 22.62 | 209.06M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:38:29 | O | 1,500 | 430.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 07/5/2024 | 07:00 | UK RNS | Zotefoams PLC Zotefoams and Shincell Global Alliance |
| 19/4/2024 | 08:44 | ALNC |  Zotefoams partner with Design Blue to create lightweight body armour |
| 19/4/2024 | 07:00 | UK RNS | Zotefoams PLC Exclusivity agreement with Design Blue Limited |
| 19/4/2024 | 07:00 | UK RNS | Zotefoams PLC 2023 Annual Report & Notice of 2024 AGM |
| 12/4/2024 | 16:34 | UK RNS | Zotefoams PLC Notification Of Transactions Of Directors/PDMRs |
| 28/3/2024 | 07:00 | UK RNS | Zotefoams PLC Director/PDMR Shareholding |
| 26/3/2024 | 14:06 | ALNC | Zotefoams welcomes Coats Group's Ronan Cox as new chief executive |
| 26/3/2024 | 13:50 | ALNC | DIRECTOR DEALINGS: Coca-Cola HBC CEO sells GBP375,000 in shares |
| 26/3/2024 | 08:36 | UK RNS | Zotefoams PLC Replacement Notice Transactions Of Directors/PDMRs |
| 26/3/2024 | 07:00 | UK RNS | Zotefoams PLC Group CEO succession |
Zotefoams (ZTF) Share Charts1 Year Zotefoams Chart |
|
1 Month Zotefoams Chart |
Intraday Zotefoams Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 07/5/2024 | 10:04 | Zotefoams with Charts & News | 2,189 |
| 07/8/2018 | 07:22 | Zotefoams (ZTF) One to Watch on Monday | 2 |
| 31/1/2018 | 21:07 | Zotefoams - Take a look at what is currently OVERLOOKED | 1 |
| 14/3/2006 | 17:09 | zotefoam | 49 |
| 26/10/2002 | 00:45 | ZOTEFOAMS is looking a bargain. forward yld 10.88% | - |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 15:38:29 | 430.00 | 1,500 | 6,450.00 | O |
| 15:35:21 | 430.00 | 3,002 | 12,908.60 | UT |
| 15:30:55 | 429.30 | 11,155 | 47,888.42 | O |
| 15:30:46 | 429.00 | 11,155 | 47,854.95 | O |
| 15:29:55 | 428.00 | 6 | 25.68 | AT |
| Top Posts |
|---|
Posted at 07/5/2024 09:20 by Zotefoams Daily Update Zotefoams Plc is listed in the Plastics Foam Products sector of the London Stock Exchange with ticker ZTF. The last closing price for Zotefoams was 432p.Zotefoams currently has 48,846,234 shares in issue. The market capitalisation of Zotefoams is £209,061,882. Zotefoams has a price to earnings ratio (PE ratio) of 22.62. This morning ZTF shares opened at 430p |
Posted at 07/5/2024 08:10 by redartbmud "Zotefoams will pay technology licensing fees of RMB 80million (approx. £9m, including capitalised deal costs*) over the 5-year term of the agreement"It does seem to be a strange move given that they are well advanced in the development of a liquids carton that has the potential to transform the business. Not sure that I would share my IP with a Chinese operation. On the face of it Ztf is 'buying' IP from the Chinese?? We have no idea of the addressable market or the lomg-term benefits for Ztf. red |
Posted at 07/5/2024 07:10 by janeann Not sure what to make of this rns ... esp as a cost of £5m to ztf |
Posted at 02/5/2024 10:56 by tonytyke2 geraldus you are right, head of steam indeed, ex-div today and the share is up nearly 4% !! |
Posted at 19/4/2024 18:17 by james188 I know a bit about Design Blue (D30), because I invest in the ProVen VCTs (Beringea)and they took a significant stake in the company back in 2015 to support the expansion of its impact protection products and international growth - particularly in the US.It was not a particularly successful investment for the ProVen VCTs and they sold out in September 2021 for a fairly modest (positive) return to Elysian Capital. I think that a US acquisition was always the most likely exit. I believe that the company is still based in Croydon and so it is a near neighbour to ZTF. We don't have any financial information in the RNS today, but it does demonstrate that ZTF is actively pursuing product development and not just concentrating on the ReZorce development project. |
Posted at 23/3/2024 13:29 by tonytyke2 Yep, thanks for the presentation link, it does give a good indication of next steps with ReZorce and the potential market here looks staggering imo.Stability testing soon, then if ok, mid May introducing the carton to trade press with the major partner announced. They have already been in contact with extrusion businesses re scaling production very quickly, but obviously will need significant external investment backing at this stage. The size of the market opportunity for ReZorce is discussed around 62m 30secs in. Indicating worldwide market is 300 billion units yearly and if production just gets to 1 billion units, this would be close to the company size of ZTF today. I think he mentioned an aim for a 10% market share?? It does sound like imo, they will have major customers near straight away, when the product is hopefully set to go. All options for the possible future business to be considered e.g. selling, licensing, joint venture/partnerships etc. All sounds extremely exciting/positive for the carton product imo, I still don't see any ReZorce development factored into the share price today, so a free carry really. The next 3- 4 months could be major company changing for ZTF, keeping my fingers crossed. Good luck with your investments here. |
Posted at 22/3/2024 13:27 by edwardt anyone know if ztf foam is going into jordan shoes?? |
Posted at 06/3/2024 15:54 by clocktower Penetrating a market that is already well supplied is not going to be easy. How will prices compare, what is needed by ZTF to be able to supply the product in volume, if they can attract customers for this alternative product? |
Posted at 05/2/2024 15:39 by pcok So Schroders increase their holdings and as the RNS released share price drops. Even after 28 years of doing this PI thing I sometimes feel I don't understand anything. Obviously (to me) any big move in share price could be a leak re reZorce so feeling a bit twitchy. Nevertheless holding tight as a good share LTBH imho. |
Posted at 18/1/2024 09:12 by someuwin Singer Note:Strong end to the year, c.5% PBT beat A very pleasing update from Zotefoams with FY23 group sales expected to be £127m, in line with consensus expectations and, reflecting a strong end to the year, adj. PBT is expected to reach £13.1m (+5% YoY), c.5% ahead of our and market expectations. This has been driven by a significant step-up (+21%) in profitability across the foam business units (polyolefin & HPP) reflecting continued progress on mix enrichment, disciplined pricing and operational efficiencies. Ahead of commercial trials in 2024, further investment in ReZorce (fully recyclable & circular barrier packaging for beverage cartons) has led to a £4.1m loss which is consistent with our modelling. The balance sheet remains strong with net debt/EBITDA of c.1.2x. We think Zotefoams is in a good shape ahead of a key year and is one of our top stock picks for 2024. There are clear share price catalysts ahead including updates on the Nike basketball partnership and newsflow on the ReZorce trial. The valuation fails to reflect the group’s upside potential in our view. BUY, TP 480p = c.45% upside. Excellent progress in foam – 2024 could be another exciting year HPP sales increased 7% whilst Polyolefin sales dropped 4%. Segment PBT is up 21% overall to £17.1m reflecting mix, disciplined pricing and continued operational efficiencies. We expect this trading momentum to continue into FY24 led by the start of a new running shoe design cycle at Nike. This should support good progress in the road running & trail shoes category, helped further by 2024 being an Olympic year. We also expect further clarity on the basketball opportunity which holds the potential for significant additional volumes. FY24 could also see the long-awaited recovery in the aviation sector where Zotefoams’ lightweight foam solutions put it at a clear competitive advantage. Reflecting strong demand in the USA and to create a better balanced footprint, investment in a second low-pressure autoclave is planned in 2024 alongside increased warehousing space. This c.£10m project will be funded from existing cash resources. We have adjusted our FY24 debt forecasts by c.£7m to £34.8m to reflect this (1.3x net debt/EBITDA ex leases). ReZorce in-market trials imminent A FY23 loss of £4.1m is as expected, reflecting investment in Rezorce (a fully recyclable & circular beverage carton) ahead of in-market trials in 1Q24. Successful commercialisation of ReZorce could be transformational for the group – please see our September note for further details (click here). Core BUY in Industrials sector We use established sector metrics for EV/sales versus EBIT margin to determine a SOTP for the Polyolefin and HPP businesses based on forward running EBIT margins in each segment. We attribute a £10m value to the MEL business segment reflecting the costs committed to ReZorce (including capitalised development costs). This drives our TP of 480p, 45% upside. |
Posted at 12/1/2024 12:13 by edwardt Ditto - I think roce can get up to 15% in next few years. This should turbo charge the share price. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
